Novartis AG (NVS)
137.16
-0.32
(-0.23%)
USD |
NYSE |
Sep 11, 16:00
140.19
+3.03
(+2.21%)
Pre-Market: 05:30
Novartis Price : 137.16 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 139.31 | 139.55 | 137.00 | 137.16 | 2.354M |
| Sep 10, 2026 | 138.76 | 139.43 | 137.46 | 137.48 | 2.420M |
| Sep 09, 2026 | 138.14 | 139.45 | 137.30 | 137.48 | 2.937M |
| Sep 08, 2026 | 139.94 | 140.46 | 137.12 | 137.70 | 10.27M |
| Sep 04, 2026 | 159.90 | 160.93 | 159.62 | 159.99 | 1.294M |
| Sep 03, 2026 | 164.48 | 164.48 | 161.42 | 163.09 | 2.453M |
| Sep 02, 2026 | 160.80 | 163.18 | 160.38 | 162.46 | 4.344M |
| Sep 01, 2026 | 162.15 | 163.57 | 160.21 | 161.25 | 4.335M |
| Aug 31, 2026 | 152.60 | 152.74 | 151.68 | 152.06 | 1.286M |
| Aug 28, 2026 | 154.51 | 154.56 | 152.77 | 153.81 | 1.166M |
| Aug 27, 2026 | 155.92 | 155.93 | 154.43 | 154.65 | 1.221M |
| Aug 26, 2026 | 158.41 | 159.19 | 157.44 | 157.54 | 1.474M |
| Aug 25, 2026 | 158.51 | 160.29 | 157.83 | 159.98 | 998182.0 |
| Aug 24, 2026 | 157.12 | 158.46 | 156.77 | 158.02 | 801261.0 |
| Aug 21, 2026 | 156.17 | 159.72 | 156.10 | 158.86 | 1.184M |
| Aug 20, 2026 | 159.07 | 159.33 | 155.87 | 156.24 | 1.526M |
| Aug 19, 2026 | 156.29 | 160.81 | 156.17 | 160.31 | 2.401M |
| Aug 18, 2026 | 153.58 | 155.10 | 153.38 | 154.55 | 1.413M |
| Aug 17, 2026 | 151.23 | 152.62 | 150.83 | 151.97 | 1.199M |
| Aug 14, 2026 | 149.39 | 151.46 | 149.09 | 150.88 | 1.598M |
| Aug 13, 2026 | 152.84 | 153.02 | 151.53 | 151.72 | 1.517M |
| Aug 12, 2026 | 152.03 | 153.43 | 151.82 | 152.32 | 2.471M |
| Aug 11, 2026 | 156.47 | 157.34 | 154.51 | 154.61 | 1.071M |
| Aug 10, 2026 | 155.84 | 156.93 | 155.39 | 156.79 | 995478.0 |
| Aug 07, 2026 | 156.56 | 156.68 | 155.38 | 156.33 | 1.309M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Roche Holding AG | 52.75 |
| AstraZeneca PLC | 160.17 |
| GSK Plc | 48.13 |
| Johnson & Johnson | 265.58 |
| Eli Lilly & Co. | 1115.70 |
Price Related Metrics
| PE Ratio | 20.69 |
| PS Ratio | 4.818 |
| Price to Book Value | 6.044 |
| Price to Free Cash Flow | 17.61 |
| Earnings Yield | 4.83% |
| Market Cap | 251.08B |
| Operating PE Ratio | 16.29 |
| Normalized PE Ratio | 19.28 |